BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12762831)

  • 1. A guide to selection and appropriate use of macrolides in skin infections.
    Parsad D; Pandhi R; Dogra S
    Am J Clin Dermatol; 2003; 4(6):389-97. PubMed ID: 12762831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dirithromycin: a new macrolide.
    Wintermeyer SM; Abdel-Rahman SM; Nahata MC
    Ann Pharmacother; 1996 Oct; 30(10):1141-9. PubMed ID: 8893122
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of macrolides and ketolides: focus on respiratory tract infections.
    Zhanel GG; Dueck M; Hoban DJ; Vercaigne LM; Embil JM; Gin AS; Karlowsky JA
    Drugs; 2001; 61(4):443-98. PubMed ID: 11324679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin.
    Bahal N; Nahata MC
    Ann Pharmacother; 1992 Jan; 26(1):46-55. PubMed ID: 1318761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The macrolides: erythromycin, clarithromycin, and azithromycin.
    Alvarez-Elcoro S; Enzler MJ
    Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients.
    Principi N; Esposito S
    Drug Saf; 1999 Jan; 20(1):25-41. PubMed ID: 9935275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin and clarithromycin: overview and comparison with erythromycin.
    Whitman MS; Tunkel AR
    Infect Control Hosp Epidemiol; 1992 Jun; 13(6):357-68. PubMed ID: 1320067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrolide antibiotics in paediatric infectious diseases.
    Guay DR
    Drugs; 1996 Apr; 51(4):515-36. PubMed ID: 8706592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute bacterial skin infections in pediatric medicine: current issues in presentation and treatment.
    Hedrick J
    Paediatr Drugs; 2003; 5 Suppl 1():35-46. PubMed ID: 14632104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New drugs--reports of new drugs recently approved by the FDA. Dirithromycin.
    Shinkai I; Ohta Y
    Bioorg Med Chem; 1996 Apr; 4(4):521-2. PubMed ID: 8735838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug interactions of macrolides: emphasis on dirithromycin.
    Watkins VS; Polk RE; Stotka JL
    Ann Pharmacother; 1997 Mar; 31(3):349-56. PubMed ID: 9066944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of macrolide antibacterials.
    Periti P; Mazzei T; Mini E; Novelli A
    Drug Saf; 1993 Nov; 9(5):346-64. PubMed ID: 8280403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ketolides: a critical review.
    Zhanel GG; Walters M; Noreddin A; Vercaigne LM; Wierzbowski A; Embil JM; Gin AS; Douthwaite S; Hoban DJ
    Drugs; 2002; 62(12):1771-804. PubMed ID: 12149046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The macrolides.
    Blondeau JM; DeCarolis E; Metzler KL; Hansen GT
    Expert Opin Investig Drugs; 2002 Feb; 11(2):189-215. PubMed ID: 11829712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced-generation macrolides: tissue-directed antibiotics.
    Amsden GW
    Int J Antimicrob Agents; 2001; 18 Suppl 1():S11-5. PubMed ID: 11574189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evolution and role of macrolides in infectious diseases.
    Blondeau JM
    Expert Opin Pharmacother; 2002 Aug; 3(8):1131-51. PubMed ID: 12150692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
    Brogden RN; Peters DH
    Drugs; 1994 Oct; 48(4):599-616. PubMed ID: 7528132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental therapeutic indications for the newer long-acting macrolide antibiotics.
    Moore PA
    J Am Dent Assoc; 1999 Sep; 130(9):1341-3. PubMed ID: 10492541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of macrolide antibiotics.
    Williams JD; Sefton AM
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():11-26. PubMed ID: 8478301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antipneumococcal activities of two novel macrolides, GW 773546 and GW 708408, compared with those of erythromycin, azithromycin, clarithromycin, clindamycin, and telithromycin.
    Matic V; Kosowska K; Bozdogan B; Kelly LM; Smith K; Ednie LM; Lin G; Credito KL; Clark CL; McGhee P; Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4103-12. PubMed ID: 15504828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.